Your browser doesn't support javascript.
loading
Frequency and Type of Disputed rpoB Mutations in Mycobacterium tuberculosis Isolates from South Korea / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases ; : 270-276, 2017.
Article in English | WPRIM | ID: wpr-220962
ABSTRACT

BACKGROUND:

A disputed rpoB mutation is a specific type of rpoB mutation that can cause low-level resistances to rifampin (RIF). Here, we aimed to assess the frequency and types of disputed rpoB mutations in Mycobacterium tuberculosis isolates from South Korea.

METHODS:

Between August 2009 and December 2015, 130 patients exhibited RIF resistance on the MTBDRplus assay at Asan Medical Center. Among these cases, we identified the strains with disputed rpoB mutation by rpoB sequencing analysis, as well as among the M. tuberculosis strains from the International Tuberculosis Research Center (ITRC).

RESULTS:

Among our cases, disputed rpoB mutations led to RIF resistance in at least 6.9% (9/130) of the strains that also exhibited RIF resistance on the MTBDRplus assay. Moreover, at the ITRC, sequencing of the rpoB gene of 170 strains with the rpoB mutation indicated that 23 strains (13.5%) had the disputed mutations. By combining the findings from the 32 strains from our center and the ITRC, we identified the type of disputed rpoB mutation as follows CTG511CCG (L511P, n=8), GAC516TAC (D516Y, n=8), CTG533CCG (L533P, n=8), CAC526CTC (H526L, n=4), CAC526AAC (H526N, n=3), and ATG515GTG (M515V, n=1).

CONCLUSION:

Disputed rpoB mutations do not seem to be rare among the strains exhibiting RIF resistance in South Korea.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Rifampin / Tuberculosis / Biological Assay / Korea / Mycobacterium / Mycobacterium tuberculosis Type of study: Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Tuberculosis and Respiratory Diseases Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Rifampin / Tuberculosis / Biological Assay / Korea / Mycobacterium / Mycobacterium tuberculosis Type of study: Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Tuberculosis and Respiratory Diseases Year: 2017 Type: Article